Covidien Snapshot

Click here to go back to main page.

Covidien
Brief Description With more than $10 billion in annual sales and offerings that include thousands of different products and brands, Covidien is one of the top players in the medical device industry. The company supplies health care providers with everything from generic pharmaceuticals and disposable medical products to diagnostic imaging contrast agents and surgical devices. Covidien has more than a dozen global manufacturing operations and markets its products in 140 countries. More than half of Covidien's sales are made in the US.
Revenues 2008: 9.91 billion USD
2009: 10.68 billion USD
2010: 10.43 billion USD
Net profit (2010) 1.63 billion USD
R&D expenses 2008: 341 million USD
2009: 427 million USD
2010: 447 million USD
Number of employees 41,500
Year Established 2009
Headquarters 20 On Hatch Lower Hatch Street Dublin 2, Ireland
Key People Jose Almeida (CEO)
Richard Meelia (Chairman)
Segmental revenue breakdown (2010) Medical Devices: 64%
Pharmaceutical Products: 19%
Medical Supplies: 17%
Geographical revenue breakdown (2010) US: 55%
EMEA: 25%
Rest of world: 20%